TOP 10 Innovative therapies clinical trials research and development in San Francisco, California

The UCSF Memory and Aging Center, located at 1651 4th Street in San Francisco, California, is a renowned institution specializing in memory disorders, dementia, and conditions such as progressive supranuclear palsy. Our team of specialists from various disciplines offers comprehensive evaluations, research on new therapies, and support groups for patients and their families. Valet parking is available, and we offer services such as the Enroll-HD registry study and clinical trials for Huntington's disease and Alzheimer's disease. Our goal is to improve understanding and treatment of neurodegenerative diseases through cutting-edge research and innovative approaches, such as the development of digital tools like video games for cognitive enhancement. Visit us to receive top-quality care and support for memory-related disorders.

Mission Bay Clinical Trial Place is a cutting-edge health institution located at 1700 4th Street in San Francisco, California, United States. As a leading hospital specializing in clinical trials, we offer state-of-the-art facilities and expert medical staff to provide the highest quality care to our patients. Our mission is to advance medical research and improve patient outcomes through innovative treatments and therapies. Join us at Mission Bay Clinical Trial Place and be a part of the future of healthcare.

ShangPharma Innovation is a cutting-edge health and pharmacy institution located at 280 Utah Avenue in South San Francisco, California. As a leading provider of innovative healthcare solutions, ShangPharma offers a wide range of pharmaceutical products and services to meet the diverse needs of its customers. With a commitment to excellence and customer satisfaction, ShangPharma Innovation is dedicated to improving the health and well-being of individuals in the local community and beyond. Visit us today to experience the difference in quality and care that sets ShangPharma apart from the rest.

The University of San Francisco - School of Nursing and Health Professions is a renowned institution located at 2130 Fulton Street in the vibrant city of San Francisco, California, United States. As a leading health university, the school offers a wide range of programs and resources for students pursuing careers in nursing and health professions. With a commitment to excellence in education, research, and clinical practice, the University of San Francisco provides a supportive and innovative learning environment for students to develop the skills and knowledge needed to succeed in the healthcare field. Whether you are interested in nursing, public health, or healthcare administration, the School of Nursing and Health Professions at the University of San Francisco is dedicated to preparing the next generation of healthcare professionals to make a positive impact on the health and well-being of individuals and communities.

Neurovations Research, located at 3444 Valle Verde Drive in Napa, California, is the leading independent clinical research site in the San Francisco area specializing in pain management and neurologic diseases. Our experienced team is dedicated to advancing healthcare innovation through cutting-edge research, with a focus on speeding up the delivery of medical devices, pharmaceuticals, and biologics to patients. Led by a visionary team of experts, Neurovations Research is committed to excellence in neurological research and patient care. With over three decades of experience, our leadership fosters a culture of collaboration and innovation to push the boundaries of knowledge in pain management and neurology. Our goal is to bring hope and healing to countless lives through rigorous inquiry and compassionate patient care.

The Institute of Cancer Research is a leading health institution located at 2200 Webster Street in San Francisco, California, United States. As a pioneer in cancer research, the institute is dedicated to advancing the understanding and treatment of cancer through cutting-edge research, innovative therapies, and personalized care. With a team of world-renowned scientists, clinicians, and healthcare professionals, the Institute of Cancer Research is committed to making groundbreaking discoveries that will ultimately lead to improved outcomes for cancer patients worldwide.

The Smith-Kettlewell Eye Research Institute is a leading institution dedicated to advancing the field of vision research. Located at 2318 Fillmore Street in San Francisco, California, this renowned institute is committed to improving the lives of individuals with visual impairments through cutting-edge research and innovative treatments. With a team of world-class researchers and state-of-the-art facilities, the Smith-Kettlewell Eye Research Institute is at the forefront of developing new therapies and technologies to enhance vision and restore sight. Whether you are seeking treatment for a vision disorder or are interested in participating in groundbreaking research, the Smith-Kettlewell Eye Research Institute is the premier destination for all your vision needs.

The UCSF Hematology, Blood & Marrow Transplant, and Cellular Therapy (HBC) Program, located at 400 Parnassus Avenue in San Francisco, California, is a renowned institution dedicated to providing advanced treatment options with care and compassion for patients with blood disorders and cancers. Patients from around the world seek treatment from our specialized providers, who offer innovative therapies and the opportunity to participate in cutting-edge clinical trials, including CAR T-cell therapy. As part of the UCSF Helen Diller Family Comprehensive Cancer Center, our program offers a wide range of services to support cancer patients, including support groups, exercise classes, psychosocial support, and symptom management. Our research teams are at the forefront of cell-based immunotherapy for cancer, with a focus on developing breakthrough treatments for various blood cancers and solid tumors.

The UCSF Cancer Immunotherapy Clinic, located at 1825 4th Street in San Francisco, California, is a cutting-edge institution that specializes in harnessing a patient's own immune system to fight cancer. As the clinical arm of the UCSF Cancer Immunotherapy Program, the clinic offers treatments such as cancer vaccines, cellular therapies, and experimental drugs. The institution is dedicated to providing the best possible care for cancer patients, with a campus-wide network of physicians, nurses, and laboratory scientists working together to discover innovative ways to treat cancer. The clinic also offers a variety of research studies and clinical trials to further advance cancer treatment. With a focus on patient-centered care, the UCSF Cancer Immunotherapy Clinic is committed to improving the quality of life for all cancer patients.

Eureka Research is a cutting-edge health institution located at 2271 Cecilia Avenue in San Francisco, California. Our team of dedicated researchers and medical professionals are committed to advancing the field of healthcare through innovative research and clinical trials. With a focus on improving patient outcomes and quality of life, Eureka Research is at the forefront of medical breakthroughs and advancements. Join us in our mission to discover new treatments and therapies that will shape the future of healthcare.

Almac Clinical Technologies is a leading health institution located at 221 Main Street in San Francisco, California, United States. They specialize in providing innovative clinical technology solutions to streamline and optimize the drug development process. With a focus on efficiency and accuracy, Almac Clinical Technologies is dedicated to advancing medical research and improving patient outcomes.

SHCS Mission Bay is a state-of-the-art health facility located at 1675 Owens Street in San Francisco, California. As a leading hospital in the area, SHCS Mission Bay is dedicated to providing top-quality healthcare services to patients in need. With a team of highly skilled medical professionals and cutting-edge technology, the institution offers a wide range of medical treatments and services to meet the needs of its diverse patient population. Whether you are in need of routine medical care or specialized treatment, SHCS Mission Bay is committed to delivering compassionate and personalized care to every individual who walks through its doors.

Dr. Jessica Hayward is a renowned health institution located at 1001 Potrero Avenue in San Francisco, California, United States. As a leading hospital, Dr. Jessica Hayward is dedicated to providing exceptional medical care and treatment to patients in need. With a team of highly skilled healthcare professionals and state-of-the-art facilities, patients can expect top-quality care in a compassionate and nurturing environment. Whether you are seeking routine medical services or specialized treatment, Dr. Jessica Hayward is committed to promoting the health and well-being of all individuals in the community.

Tarceva is a health institution located at 1 DNA Way in South San Francisco, California, United States. We are dedicated to making a difference in the lives of our patients, employees, and communities. Our commitment to diversity and inclusion drives us to create tangible change that will have a lasting impact. Join us in our mission to improve healthcare and make a positive difference in the world.

The California Institute for Regenerative Medicine (CIRM) is a cutting-edge institution located in South San Francisco, California. As a local government office, CIRM is dedicated to advancing stem cell research and regenerative medicine to improve human health and quality of life. With a commitment to funding innovative projects and fostering collaborations between scientists, clinicians, and industry partners, CIRM is at the forefront of pioneering medical breakthroughs. Visit us at 601 Gateway Boulevard to learn more about our groundbreaking work in the field of regenerative medicine.

The Parker Institute for Cancer Immunotherapy is a leading research institution dedicated to advancing the field of cancer immunotherapy. Located at 1 Letterman Drive in San Francisco, California, United States, the institute brings together top researchers, clinicians, and scientists to collaborate on innovative treatments for cancer. With state-of-the-art facilities and cutting-edge technology, the Parker Institute is at the forefront of developing new therapies to combat cancer and improve patient outcomes.

UCSF, located at 2400 Westborough Boulevard in South San Francisco, California, is a prestigious university where the best learners, researchers, and practitioners come together to deliver breakthroughs that heal the world. Known for its cutting-edge research and top-notch medical care, UCSF is a leader in the field of sports medicine, pediatric healthcare, and cancer research. With a focus on innovation and collaboration, UCSF is constantly pushing the boundaries of what is possible in healthcare. With over 20 locations throughout San Francisco and beyond, UCSF is a vital part of the intellectual and economic landscape of the Bay Area. Learn more about UCSF and how they are making a difference in the world.

Dr. Jocelyn Chapman is a gynecologic cancer surgeon located at 400 Parnassus Avenue in San Francisco, California. She is also the Co-director of the Multidisciplinary Approach to the Placenta Service. Dr. Chapman, a former classical pianist and avid runner, specializes in the surgical and medical treatment of gynecologic malignancies, as well as complex noncancerous diseases of the female reproductive system. She is known for her expertise in minimally invasive procedures such as laparoscopic and robotic surgery. Dr. Chapman's clinical research focuses on improving surgical and preoperative processes to ensure the best care for gynecologic cancer patients at UCSF Health. She also collaborates with cancer researchers to better understand genetic vulnerabilities in gynecologic cancer and develop targeted therapies. Her research has been published in reputable medical journals.

Dr. Felix Feng, MD is a renowned radiation oncologist located at 1600 Divisadero Street in San Francisco, California. Specializing in genitourinary cancers, Dr. Feng provides expert care for patients with high-risk aggressive prostate cancers and oligometastatic disease. He utilizes advanced therapeutic approaches such as intensity-modulated radiation therapy and stereotactic ablative radiotherapy to deliver precise and effective treatment. As a physician-scientist, Dr. Feng is dedicated to researching ways to improve outcomes for patients with prostate cancer. His laboratory focuses on identifying biomarkers associated with treatment resistance and developing targeted therapies to overcome this resistance. Dr. Feng is nationally recognized for his use of molecular biomarkers to personalize radiation therapy, and has been involved in numerous clinical trials focusing on metastatic prostate cancer.

John W Park is a renowned oncologist specializing in breast cancer treatment and research, located at 505 Parnassus Avenue in San Francisco, California. Dr. Park's laboratory focuses on developing cutting-edge technologies for studying and treating cancer, including immunotherapy and cancer-targeting vaccines. He also conducts clinical trials of new cancer treatments. With a background in research at Genentech, Dr. Park has contributed to advancements in breast cancer treatment, particularly in the area of HER2/neu protein and Herceptin therapy. At UCSF Health, Dr. Park and his team are dedicated to working towards a malaria-free world through partnerships with countries, organizations like the Bill & Melinda Gates Foundation, and utilizing technology and healthcare innovations. For the best experience when visiting UCSF Health, it is recommended to use Chrome or Firefox browsers.

Hyunseok Kang is a medical oncologist and specialized cancer researcher located at 505 Parnassus Avenue, San Francisco, California. Dr. Kang, also known as Hyu, is dedicated to providing care for adults with head and neck cancers using a variety of treatment approaches including chemotherapy, targeted therapy, and immunotherapy. His research focuses on developing new therapies for head and neck cancers through clinical trials, with a particular interest in improving the efficacy of immune checkpoint inhibitors for squamous cell carcinomas. Dr. Kang is a member of several prestigious medical organizations and has a strong background in internal medicine, hematology, and medical oncology. Prior to joining UCSF, he worked at Johns Hopkins Hospital as a medical oncologist and assistant professor of oncology. Dr. Kang is committed to advancing cancer research and treatment to improve outcomes for patients.

Dr. Hope S. Rugo, MD is a renowned breast oncologist and the Medical Director of Cancer Infusion Services located at 1825 4th Street, San Francisco, California, United States. Dr. Rugo has been a part of UCSF for several decades and specializes in caring for patients with breast cancer. She is dedicated to incorporating novel therapies into current treatments and improving the quality of care for her patients. As the director of UCSF's clinical trials program in breast oncology, she is actively involved in research focused on developing immunotherapies and targeted therapies to overcome treatment resistance in breast cancer. Dr. Rugo has received numerous awards for her excellence in patient care, education, and research. She is also a frequent lecturer on treatment and supportive care for breast cancer, both locally and internationally. In addition to her clinical work, Dr. Rugo runs the UCSF Bay Area Breast Cancer Forum, a bimonthly educational session open to breast cancer patients and their families and friends. Dr. Rugo's commitment to advancing breast cancer research and providing top-notch care makes her an invaluable asset to the medical community.

Dr. Mark M. Moasser, MD is a renowned medical oncologist specializing in breast cancer treatment and research. Located at 1825 4th Street in San Francisco, California, United States, he is dedicated to developing more effective therapies for breast cancer through his work in the laboratory and designing clinical trials for potential therapies. Dr. Moasser received his medical degree from Tufts University School of Medicine and completed his residency and fellowship training at prestigious institutions such as New York–Presbyterian Hospital and Memorial Sloan Kettering Cancer Center. His research findings have been published in numerous scientific journals and he regularly presents his work at scientific meetings. At UCSF Health, Dr. Moasser is committed to the vision of a malaria-free world and is actively collaborating with countries, organizations like the Bill & Melinda Gates Foundation, and utilizing technology and health care innovations to achieve this goal. For the best experience, it is recommended to use Chrome or Firefox when visiting UCSF Health's website.

Dr. Nicholas A. Butowski, MD is a renowned neuro-oncologist located at 400 Parnassus Avenue in San Francisco, California, United States. Specializing in brain tumors, neuroimaging, cognitive and rehabilitative neurology, and complementary therapies for neurological disorders, Dr. Butowski is the director of clinical services in neuro-oncology and a dedicated researcher at the Brain Tumor Center. With a medical degree from the University of Illinois at Chicago and training at UCSF, he is a member of prestigious medical organizations such as the American Academy of Neurology and the American Society of Clinical Oncology. Dr. Butowski is passionate about developing innovative treatments for brain tumors and enhancing the quality of life for his patients. His research includes studies on various regimens for glioblastoma and the use of CBD products for anxiety in glioblastoma patients. Committed to advancing the field of neuro-oncology, Dr. Butowski's institution offers cutting-edge treatments and personalized care for patients seeking neurological support.

Andrew H. Ko, MD is a renowned institution located at 1825 4th Street in San Francisco, California, United States. Dr. Ko specializes in colorectal and gastrointestinal cancers, with a particular focus on pancreatic cancer. He is dedicated to developing new treatment strategies, including molecularly targeted therapies, to combat cancer cell activity. Dr. Ko received his medical degree from Johns Hopkins School of Medicine and completed his residency at Beth Israel Deaconess Medical Center. He then pursued a fellowship in medical oncology at Stanford University before joining UCSF in 2001. Dr. Ko is known for his expertise in the field and his passion for piano, singing, and sports.

Dr. Adil Daud, MD is an institution located at 1600 Divisadero Street, San Francisco, California, United States. This institution is a doctor specializing in oncology and melanoma, with a focus on immunotherapy research. Dr. Daud is also a history and literature buff. He is the co-director of the Melanoma Center and conducts research to better understand melanoma biology and develop new treatments. Dr. Daud has led numerous clinical trials expanding the use of gene therapy for melanoma. He has received awards such as the Young Investigator Award from the American Society of Clinical Oncology and has been recognized as a Castle Connolly Top Doctor. The institution is conducting studies on advanced melanoma and other solid tumors, as well as investigating the genes predictive of response to anti-PD-1 therapy in melanoma. Dr. Daud and his team at UCSF Health are dedicated to advancing treatments for advanced skin cancer and working towards a malaria-free world through partnerships and innovative healthcare solutions. For the best experience, it is recommended to use Chrome or Firefox when visiting the UCSF Health website.

Loxo Oncology, Inc. is a biopharmaceutical company located at 201 Haskins Way in South San Francisco, California, United States. Specializing in the development of targeted cancer therapies, Loxo Oncology is dedicated to advancing precision medicine to improve outcomes for patients with genetically defined cancers. With a focus on innovative research and a commitment to personalized medicine, Loxo Oncology is at the forefront of the fight against cancer.

Dr. Rohit Bose, MD, PhD is a renowned genitourinary oncologist and physician-scientist located at 1825 4th Street, San Francisco, California, United States. Specializing in the care of patients with prostate cancer, Dr. Bose's research focuses on developing innovative treatment strategies for this disease. His laboratory works to understand molecular alterations in tumors and identify potential weaknesses in these alterations. Dr. Bose's research is supported by prestigious organizations such as the National Institutes of Health, United States Department of Defense, Prostate Cancer Foundation, and UCSF Benioff Initiative for Prostate Cancer Research. With a medical degree and a doctorate in molecular genetics from the University of Toronto, Dr. Bose completed his residency in internal medicine at Weill Cornell Medicine, followed by fellowships in medical oncology and advanced oncology at Memorial Sloan Kettering Cancer Center. At UCSF Health, Dr. Bose is dedicated to advancing cancer treatment through cutting-edge research and clinical trials.

Located at 1825 4th Street in San Francisco, California, Dr. Lawrence H. Fong, MD is a renowned institution specializing in oncology and immunotherapy. Dr. Fong is a genitourinary oncologist and cancer immunotherapist, known for his expertise in treating cancers of the genital and urinary organs. As a physician-scientist, Dr. Fong conducts cutting-edge research on cancer vaccines and immune checkpoint inhibitors. He leads UCSF's cancer immunotherapy program, overseeing clinical trials and research projects aimed at developing new treatments for cancer patients. Dr. Fong is a distinguished professor in cancer biology, with a strong publication record and a reputation for excellence in the field of cancer immunotherapy. The institution is dedicated to advancing the field of oncology through innovative research and personalized patient care. Visit Dr. Lawrence H. Fong, MD for the latest advancements in cancer treatment and care.

Dr. Arpita Desai, MD is an oncologist specializing in genitourinary cancers, with a focus on kidney and prostate cancers. She is dedicated to developing personalized treatment strategies for kidney cell cancer through novel imaging techniques. Dr. Desai earned her medical degree in India and completed her residency in internal medicine at SUNY Buffalo, followed by a fellowship in medical oncology at the University of Chicago. She is a member of ASCO and AACR, and has received awards for her commitment to patient care and teaching. Located at 1825 4th Street in San Francisco, California, Dr. Desai's institution is dedicated to providing cutting-edge care for cancer patients. Please note that the best browsing experience is on Chrome or Firefox.